• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A neutrophil-driven inflammatory signature characterizes the blood cell transcriptome fingerprints of Psoriasis and Kawasaki Disease

Emily

Editor, Senior Moderator
https://www.biorxiv.org/content/10.1101/2020.02.24.962621v1.full
A neutrophil-driven inflammatory signature characterizes the blood cell transcriptome fingerprints of Psoriasis and Kawasaki Disease

Arun Rawat, Darawan Rinchai, Mohammed Toufiq, Alexandra Marr, Tomoshige Kino, Mathieu Garand, Mohammed Yousuf Karim, Seetharama Sastry, Aouatef Chouchane, Damien Chaussabel

doi: https://doi.org/10.1101/2020.02.24.962621 This article is a preprint and has not been certified by peer review [what does this mean?].
...

CONCLUSIONS

Despite inherent limitations, especially in diseases where pathology predominantly occurs at local tissue sites, blood transcriptome profiling approaches may be of some use for investigations of diseases such as psoriasis. For one, samples can be obtained for transcriptome profiling with minimal risk and the approach is amenable to serial collection at multiple time points for monitoring applications. And as we have shown here another advantage stems for the availability of “contextual data” for comparative blood transcriptome fingerprint analysis. It is on this basis that we were able to contrast systemic responses across a range of disease states. And it is also on the basis of parallels that could be drawn between the fingerprints of KD and psoriasis that we are able to infer a potential benefit of repurposing anti-IL17 therapy for the treatment of KD.
 
Back
Top Bottom